article thumbnail

Number of ongoing US drug shortages reaches new high, pharmacist group says

Fierce Pharma

as of 2024’s first quarter—the highest number recorded since ASHP began tracking shortage data back in 2001. . | The American Society of Health-System Pharmacists has released new data showing there were 323 drugs in shortage in the U.S.

Biopharma 328
article thumbnail

W. Va. judge sides with drug distributors in bellwether opioid trial

MedCity News

From 2001 to 2017, the fatal overdose rate in Cabell County increased from 16.6 per 100,000. Judge finds no evidence of causation.

Biopharma 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA grants orphan drug status for Ichnos’ multiple myeloma antibody

Pharmaceutical Technology

The US FDA has granted orphan drug designation (ODD) for Ichnos Sciences’ ISB 2001 to treat patients with multiple myeloma.

FDA 52
article thumbnail

Huge inequalities found in access to myeloma clinical trials in Europe, says MPE

pharmaphorum

Led by the MPE CEE Workgroup on Access, the report – Addressing access barriers to myeloma clinical trials in Central and Eastern Europe – evaluated the number of clinical trials held in CEE countries between 1 January 2001 and 28 September 2020. Approximately 50,000 people in Europe are diagnosed with myeloma each year.

article thumbnail

SGS picks 60% stake in Nutrasource

Pharma Leaders

Founded in 2001 and headquartered in Guelph, Ontario, Canada, Nutrasource is a global contract research organisation (CRO) in the pharmaceutical and nutraceutical businesses. The company will initially buy a 60% interest in Nutrasource while having the right to pick the remaining 40% holding in 2026.

article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC.” References European Commission, (26 April 2023). Article 63 EMA (29 January 2020). Article 63 Euractiv (26 September 2023).

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. One of the key priorities of the EU’s strategy is to encourage innovation to solve unmet medical needs. Brussels; 2020.